Clinical Trial Update: Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intraperitoneal cytokine-induced memory-like natural killer cells for recurrent ovarian cancer (including histologic subtypes).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Ovarian Carcinoma
• Endometrioid Ovarian Carcinoma
• Ovarian Cancer

Drugs mentioned

• Intraperitoneal CIML NK Cells (cytokine-induced memory-like natural killer cells)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Platinum-resistant Ovarian Cancer, Recurrent Ovary Cancer | Phase 1 | Status: RECRUITING